| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |